|Dr. Robin A. Robinson Ph.D.||Chairman of Scientific Advisory Board & Chief Scientific Officer||344.97k||N/A||1957|
|Mr. Alan L. Rubino||Consultant||645.97k||N/A||1955|
|Dr. Kaiyo Nedd M.D.||Pres, CEO & Director||N/A||N/A||1974|
|Mr. Justin Frere CPA, CPA, M.B.A., MBA||CFO, Treasurer & Sec.||N/A||N/A||1973|
|Dr. Jo Ellen Schweinle M.D.||Chief Medical Officer||N/A||N/A||N/A|
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Roseland, New Jersey.
RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.